Cargando…
From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies
Over the past decades, an emerging role of phosphatases in the pathogenesis of hematologic malignancies and solid tumors has been established. The tumor-suppressor protein phosphatase 2A (PP2A) belongs to the serine–threonine phosphatases family and accounts for the majority of serine–threonine phos...
Autores principales: | Ciccone, Maria, Calin, George A., Perrotti, Danilo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329809/ https://www.ncbi.nlm.nih.gov/pubmed/25763353 http://dx.doi.org/10.3389/fonc.2015.00021 |
Ejemplares similares
-
The Basic Biology of PP2A in Hematologic Cells and Malignancies
por: Haesen, Dorien, et al.
Publicado: (2014) -
MicroRNAs in Myeloid Hematological Malignancies
por: Ciccone, Maria, et al.
Publicado: (2015) -
Editorial: The Emerging Role for PP2A in Hematologic Malignancies
por: Ruvolo, Peter P.
Publicado: (2016) -
Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link?
por: Cumbo, Cosimo, et al.
Publicado: (2022) -
Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy
por: Zerella, Jiarna R., et al.
Publicado: (2023)